Spark Eyes $108M IPO As Slew Of Life Science Cos. Set Terms
Gene therapy developer Spark Therapeutics Inc. set terms for a $108 million initial public offering Tuesday, becoming one of six life science companies to tweak anticipated public debuts this week as...To view the full article, register now.
Already a subscriber? Click here to view full article